Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

Jan. 11, 2000

Inspire's dry eye product enters phase II testing

Jan. 10, 2000

Allergan's therapy for allergic conjunctivitis approved for U.S. marketing

Dec. 27, 1999

Milestone reached by Xoma in collaboration with Allergan

Dec. 27, 1999

Allergan expands ophthalmic allergy product portfolio

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Pharmos seeks approval for Loterox in the U.K.

Dec. 20, 1999

New to the U.K. market: ophthalmic steroid from Alcon causes less IOP elevation

Dec. 16, 1999

AEterna presents promising phase I data for AE-941 in AMD

Dec. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...